Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VYCO is up from the 52Wk Low
(+15.87%) Since 01/26/15
waking up again
http://stockpumpers.blogspot.com/2015/06/vycor-medical-inc-media-alert-companys.html
Vycor Medical, Inc. Media Alert; Company's NovaVision's Vision Restoration Therapy Featured in Radio Interview
Patient Shares Success Story and How "It's the Only Option for Vision Therapy"
BOCA RATON, FL / ACCESSWIRE / June 4, 2015 /
Vycor Medical, Inc. ("Vycor") (VYCO), a provider of innovative and superior surgical and therapeutic solutions issues a media alert for NovaVision, one of its core business units. NovaVision was recently featured in radio interview with a patient discussing its unique neurostimulation therapy.
Former patient Carole Urban discusses her first-hand experience with Vision Restoration Therapy (VRT) on KSBT Radio FM 91.5 It's Your Health. Carole had had lost her sight as a result of brain damage incurred from a motorcycle accident and has regained her life after undertaking NovaVision's Vision Restoration Therapy (VRT).
Carole notes in the interview that she and her sister researched her options and that NovaVision's Vision Restoration Therapy was the only vision therapy they could find. Despite the skepticism of her physician, she says her vision was restored to 91% as a result of using it for six months.
Carole Urban was interviewed earlier this month on WYPL 89.3 FM Memphis, TN "Eye On Vision" Radio Show, the show reaches a large group of visually impaired listeners through the show's podcast. This interview was picked by the producer following hearing about Carole's ability to run again and pursue her hobbies since she got her vision back.
In April Carole had also been interviewed on iHeartRadio and WLBY 1290 on the Ann Arbor's Business Talk Radio, "The Lucy Ann Lance Radio Show". WLBY,"Ann Arbor's Talk Station carries nationally syndicated programs such as The Mike Huckabee Show, Geraldo Rivera, and John Bachelor.
NovaVision has the only commercially available, FDA cleared therapy underpinned by 15 years of research and clinical studies for the restoration of vision loss resulting from neurological brain damage of which Stroke and TBI are the most common causes.
Hear the radio interview: https://soundcloud.com/novavision-1/carole-urban-may-28
About Vycor Medical, Inc.
With corporate headquarters in Boca Raton, FL, Vycor Medical, Inc. ("Vycor") is a publicly traded company (VYCO) dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions and has a growing portfolio of FDA cleared medical solutions that are changing and improving lives every day. The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Both technologies have exceptional sales growth potential, address large potential markets, have the requisite regulatory approvals and are commercialized and generating revenue.
Vycor Medical's ViewSite(TM) Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices that hold the potential for speedier, safer and more economical brain surgeries and a quicker patient discharge. VBAS is designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery and add tangible value to the professional medical community. The company is ISO 13485:2003 compliant, has U.S. FDA 510(k) clearance for brain and spine surgeries and full regulatory approvals for brain in Australia, Brazil, Canada, China, Europe (EU - Class III), Korea and Japan and is seeking or has partial regulatory approvals in India, Russia, Taiwan and Vietnam. For an overview of Vycor Medical's VBAS see VBAS Video.
NovaVision develops and provides science-driven neurostimulation therapy and other medical technologies that help improve and partially restore sight in patients with neurological vision impairments. The company's proprietary Visual Restoration Therapy(R) (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury ("TBI"), or other acquired brain injuries. VRT is the only FDA 510K cleared medical device in the U.S. aimed at the restoration of vision for neurologically induced vision loss and can be prescribed by any physician. VRT also has CE Marking for the EU. NovaVision also provides Neuro Eye Therapy (NeET) in the EU, aimed at increasing visual sensitivity deep within the field defect.
The Company has also developed NeuroEyeCoach(TM), a therapy which is highly complementary to VRT(TM). The two therapies address different visual disabilities each of which results from neurologically-induced vision loss - a loss of visual field as well as difficulty with eye movement, affecting the ability to integrate visual information. VRT provides partial restoration of the patient's lost visual field; NeuroEyeCoach(TM) is designed to increase the efficiency of eye movement and re-train the patients' ability to integrate visual information between the left and right hand side. For an overview of NovaVision see NovaVision Video.
http://player.vimeo.com/video/39765566
For the latest information on the company, including media and other coverage, and to learn more, please go online at http://www.vycormedical.com, http://www.vycorvbas.com or http://www.novavision.com.
How Exciting to be here on my surf board when a prodigous waive greets those invested for a unforgetable ride!
VYCO one for 150 reverse split:
http://www.otcbb.com/asp/dailylist_detail.asp?d=01/14/2013&mkt_ctg=NON-OTCBB
VERT on bid @ .009 !!!
The original investors are going to be holding this one for a long while, if they in fact signed an agreement to not sell until this reaches .08
Passing the 52 week low, c'mon with some news already
Solid products, that sell themselves (when the word gets out). Unfortunately, that still needs to happen.
man this is still here...hopefully it blasts off soon
Good way to start the week. Some news would be nice (i.e. necessary).
Looks like the board has been super-quiet for some time, now. Any word on updates from the company or anything?
Good (late) morning, folks! Wow! Last week was pretty quiet here, if the number of posts is any indication. I was out due to a runner (me)-car accident (little old lady decided to see if I would bounce when struck by her car...fortunately, I did hahaha!) but what happened to everybody else? And what's this about an IPO?
Can anyone here tell me why VYCO has posted for an IPO?
Morning again, folks! Well, not much happened yesterday that was worthy of too much remark, I see. That's alright, that's okay...because this stock's gonna make us rich someday!!
Morning, medical mavens! A tiny bit of movement this morning. Sooner or later, this one's gonna fly!
Hey guys new on this board! I have done some DD, but can some 'smarty' update me here?
What's next on the agenda for Vycor?
I've been watching from the sidelines for some time and will be looking to initiate a position soon.
What do we have to look forward too in the next few weeks / months?
Pretty quiet around here yesterday. Musta been the post-Labor Day blues. You know; back to school, back to work, back to all the headaches? Well, new day, new week and new month for VYCO, so there's always that, right?
Morning, VYCO stock studs! New month, new opportunities for success.
According to Iflub, both of the supports, the pivot, and resistance points are all at .015? Has L2 changed since yesterday? Still stacked on .019, or has it come down?
$$VYCO nice end of month ask buying day so far..nice way to end the month..bring on the new..
And the uphill climb begins as investors fill up on the cheap.
"Safest OTC plays..." indeed, Sir John Thundercleese. I agree 100 percent. I'm amazed it's not sitting at a nickel yet, but it WILL be there soon enough, IMHO.
It funny to say but imho vyco is one of the safest otc plays I have seen in a long time
Well a quite day...lets see some green
VYCO needs some pressure on ask to start moving again
Vycor marketing strategy very wise to focus on growing international market, 60% of sales outside of USA
VYCO Novavision is the only FDA approved product that actually cures stroke related blindness
Actually I got in on that call. Richard Denness strong Big Pharma pedigree is exactly the right addition at the right time for Vycor's international market expansion
VYCO has all the necessary ingredients, add a litle more awareness here and we'll burn through our little seller quick
Good to see you again kiwi, you missed a good CC this week. VYCO still holding strong. Who knows where this could go with a little marketing..?
Its our retail piker thats been hiding behind his mama's apron
VYCO is such a strong package its obvious how undervalued it is at this level, its a cinch for this to go to 5's or 6's before its all said and done. A long position is the only one that makes sense here. It's really a set it and forget deal for me.
Hi K1w1, nice to see you're still long here, haven't seen you on the board in awhile
3 reasons I'm long on VYCO:
--2 already FDA approved, patented, revolutionary neurological medical devices already penetrating a global multibillion dollar industry
--Strong endorsement from the top thought leaders of the scientific and medical community, i.e. John Hopkins and Harvard Medical school faculty
--VBAS product makes impossible brain surgeries and Novavision actually restores sight to stroke victims, whats not to like?
Should be interesting to see tomorrow's action because of the holiday. Another volatile friday is in order.
Wow, that's quite a stack on .019. Hopefully those .018s will be eaten up to beef up the .015
I almost forgot, wonder how a forthcoming 3 day weekend will impact end of week trading here
It's been a slow day for VYCO. Holiday weekend coming up, I wouldn't be suprised to see the action heat up here as end of week approaches
VYCO needs more bid action to close up that spread
How's the bid support looking?
Slow day, nice to see VYCO holding its own at.018 but I'd like to see that spread close up and some more volume.
Morning, VYCO stock studs! How we looking today?
$$VYCO nice ask slap again to start the day
Not a bad day...VYCO is just fundamentally strong. The Story will come through and we will see growth imho
I believe the agreement with the inside holders is that they won't sell until .08
Followers
|
33
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2964
|
Created
|
10/06/09
|
Type
|
Free
|
Moderators |
VYCO Vycor Medical Inc.
Websites:
http://www.vycormedical.com/
http://www.novavision.com/
VYCO videos: http://player.vimeo.com/video/39903199
http://www.vycormedical.com/videos/videos.html
--------------------------------------------------------------------------------------------------------------------
About Vycor Medical Inc..
Vycor Medical, Inc. is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. Vycor's innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. The Cure Should Never Prove Worse Than the Condition.
Vycor Medical was founded on this basic challenge: "There must be a better way". A better way to access surgical locations without unduly damaging surrounding tissue. A less invasive means to perform critical procedures, so that collateral trauma can be minimized and postoperative recovery accelerated. And a better breed of surgical access instrumentation for enhancing performance, safety and results such as the Vycor ViewSite Surgical Access Systems, our premiere product line.
----------------------------------------------------------------------------------------------
TAKE A LONG HARD LOOK AT VYCO:
=====> VYCO's NovaVision technology is the only FDA cleared treatment that restores vision lost by victims of stroke and traumatic brain injury.
Vycor NovaVision product offering is the first real, tested, proven treatment for a type of vision loss which the medical community has considered untreatable for over a hundred years. NovaVision literally restores sight to the blind. VYCO has generated a legitimate medical breakthrough.
"NovaVision provides a home-based treatment of vision rehabilitation after stroke or brain injury called Vision Restoration Therapy (VRT™). VRT is an FDA-cleared, patented, non-invasive medical device that enhances visual functions in patients with impairments due to stroke, surgical intervention, and traumatic brain injury (TBI). "
"70% of cases patients using NovaVision's VRT system over a three to six month period experience significant recovery in at least one functional outcome. In many cases this recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some cases even driving a car."
"Stroke and traumatic brain injury (TBI) victims are almost always told by their doctors that vision loss causedby neurological brain damage is permanent and irreversible; these doctors have been taught this "fact" since early in their careers, and they mostly accept it as a fact, without question. However, according to six Company-sponsored studies and fourteen independent studies, conducted over a period of 15 years, this is not a fact at all. It is instead a previously-valid medical conclusion based on old data and technology - it is not based on current research. We believe the new data regarding recently-developed technology (i.e. NovaVision's VRT and NeET) have clearly shown that vision loss can be at least partially restored in most cases..."
Read up on the science and research here, including 15 years of research and 20 clinical studies: http://www.novavision.com/clinical-studies
Every year, 795,000 victims in the US alone suffer a stroke. http://www.cdc.gov/stroke/facts.htm
====> VYCO's ViewSite technology makes previously inoperable brain surgeries possible.
The ViewSite™ system is a revolutionary approach in brain retraction and access. It dramatically reduces the damage done by "retractors" used by neurosurgeons when reaching subsurface areas of the brain.
http://www.vycormedical.com/products/products.html
"The net effect of this is improved clinical outcomes, shorter surgeries, and shorter recovery times; in some cases this product's superior attributes have allowed brain surgeons to successfully perform surgeries that would have otherwise been considered inoperable."
VYCO technology is saving lives.
Doctor testimonials: http://www.vycormedical.com/products/testimonials.html
Clinical reports: http://www.vycormedical.com/products/reports.html
"Since its introduction in 2010, the ViewSite Brain Access System has been used to perform over 3,000 brain surgery procedures, and it has either been approved or is being evaluated by some 130 hospitals in the United States alone."
====> VYCO is penetrating a $20B international market.
"VYCOR Should Enter Hyper-growth During the Next Two to Three Years. Vycor's ViewSite is already making good inroads into the relatively small neurosurgery market, both in the U.S. and overseas, and we expect sales to grow robustly beginning in early 2013. However, we are most excited about the long-term potential of the NovaVisionsubsidiary, as its products have no real competition and address a global market that could be up to $20B in size. Although NovaVision's products could require several years to achieve market penetration of even 5%, this would still equate to a huge win for a company of this size. Both NovaVision and ViewSite have strong patent protection and backing from the scientific community, and both are FDA 510(k) cleared for sale in the United States." -- from the Harbinger Report
VYCO VRT treatment has already treated 2,000 patients. A $170,000 shipment was made to China in December, 2011. VYCO technology is already being used in hundreds of hospitals worldwide.
Vycor distributors are international, and aside from the US, include Australia, China, Japan, the Benelux, Greece, Italy, Spain, Sweden and the UK. 39% of revenue comes from sales outside the US, 32% of which is China. http://www.vycormedical.com/products/distributors.html
====> VYCO Revenues up. Forecasts call for revenues of $2.9mm in 2012, $5.3mm in 2013
"Revenue up 198% Over First Quarter 2011; Vycor Medical Division Revenue up 222% Over 2011, NovaVision Division up 145%; Net Loss Reduced"
http://finance.yahoo.com/news/vycor-medical-inc-reports-first-130000889.html
Harbinger Research report: http://a.eqcdn.com/harbingerresearch/media/b767cf61ff1d00bcf70bf414fab946a5.pdf
SEC filings: http://ir.vycormedical.com/SEC
====> VYCO has strong patent protection, FDA clearance for NoraVision and ViewSite, and little competition.
The Company has a very strong patent portfolio with 30 granted patents and 30 patents pending, providing it with significant IP protection and creating strong barriers to entry by would-be competitors.
More patent details here:http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76489668
FDA and regulatory: http://ir.vycormedical.com/FDA_and_Regulatory
NovaVision's VRT is the only FDA 510(k) cleared medical device that is used to restore visual field loss that results from neurological trauma.
====> VYCO team includes veteran industry management and international medical luminaries.
http://ir.vycormedical.com/profiles/investor/Management.asp?BzID=2090
The NovaVision advisory board reflects the caliber of international medical luminaries who resoundingly support Vycor's breakthrough technology. Alvaro Pascual-Leone, MD PhD is Professor of Neurology at Harvard Medical Shool. He is one of many highly respected medical leaders who warmly commend Vycor technology to their patients and peers
http://www.novavision.com/advisory-board-alvaro-pascual-leone
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |